... by Matt Noah
A network of medtech, biotech and life science professionals.
Home
Free Membership
Web Forum
CEO Roundtable
Executive Search
Founders
Contact Us
MN VC Conference
MASVF Conference
NetSuds

To network is to make use of one's membership of a network, one's contacts, etc. to acquire information or some professional advantage, often while appearing to be engaged in social activity.
- The Oxford Dictionary of New Words, 1991.
 

MedSuds
980 Lake Susan Hills Drive
Chanhassen, MN  55317
Phone: 1.612.605.5252
Fax: 1.612.677.3934

 
Web sites powered by:

Entrepreneurs Breakfast*

Tuesday, November 15, 2005, 7:00 am, Double Tree in St. Louis Park
$42* on or before November 8, $60 afterwards*
 

or

Linda Hall Whitman, COO or
Michael Howe, CEO
Kevin Nickels, CEO John Deedrick, Managing Director
MinuteClinic Celleration Accuitive Medical Ventures

 

Sponsor

 

Pre-Registration Is Closed.  To Attend, ...

... Download Credit Card/Check payment form and bring with you to the event.

Program

6:30 - Registration and Badge Pick-Up. 6:40 - Breakfast Buffet. 7:00 - Matt Noah & Sponsor Remarks. 7:15  Presentations.  8:30 Concluding Remarks.

We will have 3 speakers.  We will hear from John Deedrick, Managing Director, Accuitive Medical Ventures, 507.529.4003, john@amvpartners.com Mike Howe, CEO, MinuteClinic, 612.767.1916, michael.howe@minuteclinic.comKevin Nickels, CEO, Celleration, 952.224.8700, knickels@celleration.com

 

Celleration is a privately held medical device company was founded in 1999, to develop and commercialize its therapeutic ultrasound platform. The patented MIST Technology™ utilizes ultrasonic sound waves to produce an energized mist of sterile saline in a non-contact fashion. Critical to the Company’s strategy is ongoing clinical and scientific research to provide evidence supporting the efficacy of this new technology. The Company’s initial clinical research focus has been the chronic diabetic foot ulcer market and it has recently completed a randomized, sham controlled multi center study in diabetic foot ulcers to pursue additional indications for the MIST Technology. Additional randomized controlled clinical trials are underway to add to the understanding and body of evidence supporting the MIST Technology.  On August 15, 2005 Celleration received $16M in venture funding.  www.celleration.com

MinuteClinic has found a fundamentally better way to diagnose common illnesses and provide the right remedy, quickly and conveniently.  At MinuteClinic, you get personal attention from certified practitioners who are qualified to evaluate, diagnose and prescribe medication for your symptoms.  No appointment needed, just walk in.  Visits take approximately 15 minutes.  Affordable treatments range from $28 to $110 and are reimbursable through most insurance plans.  Retail locations open 7 days a week at various locations near pharmacies.  urs vary by location.  USA Today featured MinuteClinic as new and innovative.  In the Rx for the Ailing Health Care System , a book to be published by Professor Clayton Christensen, features MinuteClinic illustrating many of the author's principles for transforming the health care industry.  During the Summer of 2005 MinuteClinic received $43M in venture funding.  www.minuteclinic.com

Accuitive Medical Ventures (AMV) is a venture capital firm with offices in Atlanta, GA, Newport Beach, CA, and Rochester, MN. AMV is in business to finance and help develop early and expansion stage medical device and technology companies.  In conjunction with The Innovation Factory (www.innofactory.com), the Atlanta based medical device incubator, AMV has the resources and the experience to create long-term value for medical technology inventors and innovators.  The AMV team has significant executive management, operating and board experience, as well as demonstrated expertise in sourcing, financing and exiting successful medical device companies. They have collectively co-founded 15 companies, raised over $250 million in private equity capital and have participated in private and public equity financings of well over $700 million while creating over $1 billion in shareholder value in their careers www.amvpartners.com


* Copyright © 1998-2006 by NetSuds.com, Inc. All Rights Reserved. Permission to reprint is granted for non-commercial purposes.  All Registration Payments are Final and Non-refundable.  NetSuds makes every effort to ensure that listed speakers and program will occur as presented.  There are circumstances where speakers may not be able to participate as planned.  In that case, NetSuds will make efforts to replace listed speakers.